Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 20/20 | 0.68 |
| ▸ | RARG | P13631 | 14/20 | 0.68 |
| ▸ | RXRB | P28702 | 7/20 | 0.68 |
| ▸ | RXRG | P48443 | 7/20 | 0.68 |
| ▸ | RARA | P10276 | 6/20 | 0.68 |
| ▸ | RARB | P10826 | 6/20 | 0.68 |
| ▸ | PPARG | P37231 | 14/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6297007 | 0.91 | RXRA (0.56) | RXRARARGRXRBRXRGRARA | |
| SCHEMBL6279295 | 0.85 | RXRA (0.48) | RXRARARGRXRBRXRGRARA | |
| SCHEMBL6279289 | 0.85 | RXRA (0.48) | RXRARARGRXRBRXRGRARA | |
| SCHEMBL6450239 | 0.83 | RXRA (0.46) | RXRARARGRXRBRXRGRARA | |
| SCHEMBL6311880 | 0.83 | RXRA (0.46) | RXRARARGRXRBRXRGRARA | |
| SCHEMBL6275714 | 0.80 | TSHR (0.47) | RXRARARGRXRBRXRGRARA | |
| SCHEMBL6283376 | 0.79 | RXRA (0.59) | RXRARARGRXRBRXRGRARA | |
| SCHEMBL6283134 | 0.77 | HNF4A (0.40) | RXRARARGRXRBRXRGRARA | |
| SCHEMBL6278635 | 0.76 | HNF4A (0.39) | RXRARARGRXRBRXRGRARA | |
| SCHEMBL6278629 | 0.76 | HNF4A (0.39) | RXRARARGRXRBRXRGRARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6887896-B1 | 7-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity | ALLERGAN, INC. (US) | 2005-05-03 | — | — | US | disclosed |